Seeking Alpha

The FDA has proposed new rules that would require the makers of emergency defibrillators to...

The FDA has proposed new rules that would require the makers of emergency defibrillators to submit data clinical-trial data for their devices or provide other evidence that they work. The move comes after 45,000 malfunctions and 88 product recalls from 2005-2012. Leading manufacturers include Philips (PHG), Physio-Control and Zoll Medical (ZOLL).
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector